eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
4/2012
vol. 37
 
Share:
Send email
Share:
abstract:

Clinical immunology
Gastric cancer increase the percentage of intermediate (CD14++CD16+) and nonclassical (CD14+CD16+) monocytes

Andrzej Eljaszewicz
,
Michal Jankowski
,
Lidia Gackowska
,
Anna Helmin-Basa
,
Malgorzata Wiese
,
Izabela Kubiszewska
,
Wojciech Kaszewski
,
Jacek Michalkiewicz
,
Wojciech Zegarski

(Centr Eur J Immunol 2012; 37 (4): 355-361)
DOI: https://doi.org/10.5114/ceji.2012.32725
Online publish date: 2013/02/10
View full text Get citation
 
PlumX metrics:
Introduction: Gastric cancer is one of the most common malignancies diagnosed worldwide. Despite therapeutic options, prognosis is unfavorable, particularly when dealing with an advanced stage carcinoma. Similarly to other malignancies, the development of gastric cancer is associated with increased macrophage infiltration. Monocytes are peripheral blood precursors of tissue macrophages. In the relation to the expression of CD14 and CD16 receptors, human peripheral blood monocytes can be divided into: “clasical monocytes” CD14++CD16–, intermediate monocytes CD14++CD16+ and non-classical monocytes CD14+CD16+. However, little is known about monocytes involvement in the regulation of immune response in patients with gastric malignancies.

Material and methods: In this study, the phenotype of peripheral blood monocytes was determined in patients with gastric tumors by flow cytometry. We also analyzed the level of interleukin 10 (IL-10) and tumor necrosis factor α (TNF-α) production after 24 h stimulation of peripheral blood mononuclear cells with lipopolysaccharide. The results obtained in group of gastric cancer patients were compared to those of age-matched group of healthy individuals.

Results: We observed a significant decrease in percentage of monocytes in the peripheral blood of gastric cancer patients as compared to healthy donors. Moreover gastric cancer patients shows a significant decrease of CD14++CD16– monocytes subpopulation and an increase in CD14++CD16+ and CD14+CD16+ monocytes subpopulations as compared to healthy volunteers. In stomach cancer patients we also have observed increased production of IL-10 as compared to controls.

Conclusions: In summary, this study has revealed that gastric malignancies significantly modulate the phenotype of peripheral blood monocytes giving them anti-inflammatory properties. Therapeutic targeting of anti-inflammatory monocytes in the peripheral blood could modulate the complex activities of macrophages in tumor environment.
keywords:

gastric cancer, CD14++CD16–, CD14++CD16+, CD14+CD16+, IL-10, TNF-α, flow cytometry

Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.